NASDAQ:NVCR

Novocure Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy NVCR

*Your capital is at risk

$16.15

+0.330 (+2.09%)

At Close: Jun 03, 2026

NovoCure Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 34.29. In total, the insiders bought 2.79M and sold 223.1K NVCR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	34.29
● Buy	2.79M shares
● Sell	223.1K shares
76% Buy Activity Moderate Positive Correlation
Sell Signal Low Confidence Mar 05, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 34.29. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 03, 2026 Sell	Ordinary Shares S-Sale	Doyle William F Executive Chairman	CEO / President	21 330 Value: $286.4K
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Doyle William F Executive Chairman	CEO / President	30 072 Value: $400.0K
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Doyle William F Executive Chairman	CEO / President	258 445 Value: $3.44M
Mar 03, 2026 Buy	Ordinary Shares A-Award	Doyle William F Executive Chairman	CEO / President	200 000 Value: $2.66M
Mar 02, 2026 Sell	Ordinary Shares S-Sale	Weinberg Uri Chf Medical And Innovation Ofr	Officer	3 272 Value: $43.6K
Mar 02, 2026 Sell	Ordinary Shares S-Sale	Leonard Frank X Chief Executive Officer	CEO / President	7 232 Value: $97.6K
Mar 02, 2026 Sell	Ordinary Shares F-InKind	Cordova Ashley Former Chief Executive Officer	CEO / President	2 410 Value: $32.9K
Mar 02, 2026 Sell	Ordinary Shares F-InKind	Cordova Ashley Former Chief Executive Officer	CEO / President	7 228 Value: $98.8K
Feb 28, 2026 Buy	Ordinary Shares A-Award	Weinberg Uri Chf Medical And Innovation Ofr	Officer	12 992 Value: $209.8K
Feb 28, 2026 Buy	Ordinary Shares A-Award	Leonard Frank X Chief Executive Officer	CEO / President	18 621 Value: $300.7K
Feb 28, 2026 Buy	Ordinary Shares A-Award	Cordova Ashley Former Chief Executive Officer	CEO / President	23 818 Value: $384.7K
Feb 28, 2026 Buy	Ordinary Shares A-Award	Ben Arye Barak General Counsel	Officer	17 755 Value: $286.7K
Feb 27, 2026 Sell	Ordinary Shares S-Sale	Weinberg Uri Chf Medical And Innovation Ofr	Officer	7 461 Value: $103.3K
Feb 27, 2026 Sell	Ordinary Shares S-Sale	Puri Michal Nath Chief Human Resources Officer	Officer	1 441 Value: $19.7K
Feb 27, 2026 Sell	Ordinary Shares S-Sale	Leonard Frank X Chief Executive Officer	CEO / President	9 734 Value: $133.0K
Feb 27, 2026 Sell	Ordinary Shares F-InKind	Cordova Ashley Former Chief Executive Officer	CEO / President	11 541 Value: $158.7K
Jan 11, 2026 Sell	Ordinary Shares F-InKind	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	2 133 Value: $30.6K
Dec 31, 2025 Buy	Common Stock J-Other	Ben Arye Barak Insider	Other	0 Value: $0
Dec 31, 2025 Buy	Common Stock J-Other	Danziger Asaf Insider	Other	0 Value: $0
Dec 31, 2025 Buy	Common Stock J-Other	Puri Michal Nath Insider	Other	0 Value: $0
Nov 04, 2025 Sell	Ordinary Shares F-InKind	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	2 949 Value: $36.1K
Nov 04, 2025 Sell	Ordinary Shares F-InKind	Brackmann Christoph Chief Financial Officer	C-Suite Officer	7 033 Value: $86.0K
Nov 01, 2025 Sell	Ordinary Shares F-InKind	Leonard Frank X EVP, Pres., Novocure Oncology	Officer	966 Value: $12.4K
Nov 01, 2025 Sell	Ordinary Shares F-InKind	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	168 Value: $2K
Oct 31, 2025 Sell	Ordinary Shares F-InKind	Puri Michal Nath Chief Human Resources Officer	Officer	752 Value: $10K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVOCURE LIMITED

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c...

Read Full Profile Here